Status:
COMPLETED
Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement
Lead Sponsor:
Shanghai Chest Hospital
Conditions:
Persistent Atrial Fibrillation
Right Atrial Enlargement
Eligibility:
All Genders
18-80 years
Brief Summary
This is retrospective cohort study testing whether patients with persistent atrial fibrillation and right atrial enlargement may benefit from adjunctive right atrial ablation.
Detailed Description
This is retrospective cohort study testing whether patients with persistent atrial fibrillation and right atrial enlargement may benefit from adjunctive RA ablation. We enrolled 65 patients with pers...
Eligibility Criteria
Inclusion
- Aged 18 to 80 years old;
- Persistent AF with right atrial enlargement;
- Nonresponse or intolerance to ≥1 antiarrhythmic drug.
Exclusion
- History of catheter ablation;
- valvular heart disease;
- hypertrophic cardiomyopathy or dilated cardiomyopathy;
- Without follow-up data
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2022
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT05227586
Start Date
November 1 2021
End Date
January 20 2022
Last Update
February 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mu Qin
Shanghai, China, 200030